SecondWave Systems Brings New Investor to Expanded Series A to Accelerate Development of Novel Ultrasound-Based Anti-Inflammatory Treatment

Barchart · 10/22/2025 09:29

ST. PAUL, Minn., Oct. 22, 2025 /PRNewswire/ -- SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders, announced a new investment to expand its Series A syndicate. New investor Sectoral Asset Management joins an experienced syndicate of medical technology investors, including Treo Ventures, Scientific Health Development, University of Minnesota, and a major healthcare strategic.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.